Tags
Language
Tags
December 2024
Su Mo Tu We Th Fr Sa
1 2 3 4 5 6 7
8 9 10 11 12 13 14
15 16 17 18 19 20 21
22 23 24 25 26 27 28
29 30 31 1 2 3 4

Pharmaceutical Market Access

Posted By: ELK1nG
Pharmaceutical Market Access

Pharmaceutical Market Access
Published 4/2024
MP4 | Video: h264, 1920x1080 | Audio: AAC, 44.1 KHz
Language: English | Size: 5.63 GB | Duration: 2h 19m

Unlocking the Pathways to Innovation and Patient Care

What you'll learn

Master key market access strategies to launch successful pharmaceutical products globally

Gain expertise in health economics, pricing strategies, and regulatory frameworks, essential for pharma careers

Learn to navigate the payer ecosystem for optimal drug reimbursement and broader patient access

Understand the impact of health technology assessments (HTAs) and real-world evidence in drug approval

Acquire skills in stakeholder engagement and effective communication to influence healthcare decisions

Explore cutting-edge digital health technologies that are reshaping market access in the pharmaceutical industry

Prepare for high-demand market access roles with hands-on case studies from industry experts

Discover the role of patient advocacy in improving access to medications and shaping healthcare policies

Dive into global market access considerations, understanding diverse healthcare systems and policies

Equip yourself with the knowledge to ensure innovative drugs reach patients in need, enhancing healthcare outcomes

Requirements

No specific prerequisites are required for this transformative journey into Market Access. Whether you're new to the pharmaceutical industry or looking to expand your expertise, this course is crafted to welcome anyone with a passion for making a difference in healthcare. Embrace the opportunity to propel your career into a future where your impact is immeasurable. Let your curiosity and desire to contribute to medical innovation be your guide.

Description

Embark on an enlightening adventure into the pivotal world of Pharmaceutical Market Access, a crucial domain pivotal to the advancement of healthcare and patient well-being. This detailed and expansive course delves deep into the core aspects of Health Technology Assessment (HTA), Real World Evidence (RWE), Health Economics and Outcomes Research (HEOR), Patient Access, Innovation, and Early Access, uncovering the layers and complexities involved in bringing revolutionary medical treatments from conception to the hands of those in need.With a curriculum designed for both seasoned professionals and newcomers eager to leave their mark in the pharmaceutical sector, this course offers a rare glimpse into the strategic and operational facets of market access. You will be equipped with the knowledge to not only understand but also influence the multifaceted decision-making processes that determine the success and reach of new healthcare solutions.Through a blend of theoretical knowledge and practical insights, gain the expertise to navigate the regulatory landscapes, understand the economic impact, and advocate for patient access to essential medications. Learn from industry experts and case studies that bring to life the challenges and triumphs of ensuring that groundbreaking therapies are available, affordable, and attainable for patients around the globe.This course is your gateway to becoming a key player in the pharmaceutical industry, where you'll be empowered to drive innovation, influence healthcare policy, and contribute to the shaping of future medical breakthroughs. By enrolling, you're not just signing up for a course; you're stepping into a community dedicated to making a lasting impact on global health. Your journey towards mastering Pharmaceutical Market Access starts here. Seize this opportunity to be at the forefront of healthcare evolution, and play a part in delivering hope and healing to millions worldwide.

Overview

Section 1: Introduction to Market Access

Lecture 1 Introduction

Section 2: Health Technology Assessment (HTA)

Lecture 2 Learning materials

Lecture 3 HTA introduction

Lecture 4 Decoding HTA: The key to pharmaceutical market access

Lecture 5 Decoding global HTA practices

Lecture 6 Stakeholder engagement: The heart of HTA

Lecture 7 Mastering HTA: A strategy for market access

Section 3: HEOR (Health Economic & Outcome Research)

Lecture 8 Learning materials

Lecture 9 HEOR: The backbone of healthcare decision making

Lecture 10 Decoding health economics

Lecture 11 Fundamentals of outcomes research

Lecture 12 Decoding data sources & methodologies in HEOR

Lecture 13 Unraveling the power of HEOR modelling

Lecture 14 Decoding PROs: The patient´s voice

Lecture 15 HEOR: The game changer in drug development

Lecture 16 Decoding HEOR: A regulatory and payer perspective

Section 4: Real World Evidence

Lecture 17 Learning materials

Lecture 18 RWE: A transformative approach in healthcare

Lecture 19 Unveiling the sources of RWE

Lecture 20 Regulatory framework for RWE

Lecture 21 RWE in drug development and market access

Lecture 22 Decoding RWE: Methodologies and techniques

Lecture 23 Navigating the Challenges of RWE

Section 5: Patient Access

Lecture 24 Learning materials

Lecture 25 Unlocking patient access

Lecture 26 Unveiling the barriers to patient access

Lecture 27 The power of patient advocacy

Lecture 28 Patient access schemes

Lecture 29 Decoding regulatory fremaworks for patient access

Lecture 30 Stakeholder engagement for improved patient access

Section 6: Early Access

Lecture 31 Learning materials

Lecture 32 Unlocking early access mechanisms

Lecture 33 Early access in UK

Lecture 34 Early access in Italy

Section 7: Innovation

Lecture 35 Learning materials

Lecture 36 Innovation in HTA

Lecture 37 Unleashing healthcare innovation: The european approach

Lecture 38 Mastering innovation in HTA

Lecture 39 Innovation. schemes in UK healthcare

Lecture 40 Italy: Example of innovation

Lecture 41 Innovation in French healthcare

Section 8: Regulatory

Lecture 42 Learning materials

Lecture 43 Navigating the regulatory affairs in market access

Lecture 44 Decoding the FDA´s drug approval pathway

Lecture 45 EMA (European Medicine Agency)

Section 9: EUnetHTA

Lecture 46 Learning materials

Lecture 47 Common joint assessments

Lecture 48 EUnetHTA: Shaping market access in Europe

This course opens doors to one of the most rewarding and high-demand careers in the pharmaceutical industry: Market Access. If you're intrigued by the crucial role of bringing medical innovations to the patients who need them, this course is designed for you. Tailored for both newcomers eager to learn how drugs are brought to market and professionals aiming to advance their careers within pharmaceutical companies, life sciences consulting, or HEOR (Health Economics and Outcomes Research) analysis. Take the first step towards a career where your work is not only well-compensated but also makes a meaningful difference in people’s lives. Join us and become an expert in Market Access, a field with boundless growth and opportunities!